North America Needle-Free Injection Systems Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Product (Fillable Needle-free Injectors and Prefilled Needle-free Injectors), Technology (Jet-Based Needle-free Injectors, Spring-Based Needle-f

North America Needle-Free Injection Systems Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Product (Fillable Needle-free Injectors and Prefilled Needle-free Injectors), Technology (Jet-Based Needle-free Injectors, Spring-Based Needle-free Injectors, Microarray Patch Injectors, and Others), Type (Liquid-Based Needle-free Injectors, Projectile-based Needle-free Injectors, and Powder-Based Needle-free Injectors), Usability (Disposable and Reusable), Site of Delivery (Subcutaneous Injectors, Intramuscular Injectors, and Intradermal Injectors), Application (Vaccine Delivery, Insulin Delivery, Oncology, Pain Management, Dermatology, and Others), and End User (Hospitals, Home Care Settings, Research Laboratories, Pharmaceutical & Biotechnological Companies, and Other End User)

The North America GMP testing service market is expected to grow from US$ 846.02 million in 2022 to US$ 1,260.96 million by 2028; it is estimated to grow at a CAGR of 6.9% from 2022 to 2028.

Flourishment of Medical Device Industry Bolsters North America GMP Testing Service Market Growth

The medical devices industry is contributing to the development of medical technologies that have the potential to reinforce the diagnosis and treatment of various illnesses and support the effective manufacturing of medical devices. The equipment produced by the medical devices industry range from common supplies such as surgical masks to high-tech imaging equipment. Medical devices such as insulin delivery systems, glucose monitors, oxygen concentrators, and nebulizers are increasingly being used for the at-home diagnosis and treatment of a few medical disorders. These devices are integrated with the patient’s EMR, wearables, cellphones, and telehealth platforms to provide critical insights for enhanced clinical and operational decision-making. According to data provided by PRODSMART, the medical devices manufacturing industry was valued at ~US$ 4.2 billion in 2020. A rise in the incidence of chronic diseases and the growth of the geriatric population are the major factors that are expected to influence the progress of the medical device industry in the coming years. The operations of medical devices with Internet of Medical Things (IoMT) systems are facilitated by smart gadgets, smart sensors, and other lightweight communication devices. Such innovations assist healthcare companies in improving patient outcomes, lowering costs, and increasing efficiency. The GMPs are enormously important in the manufacturing of medical devices because they ensure a level of quality, safety, purity, and strength in any products that are released to the public. Adhering to these practices helps manufacturers in preventing adverse effects, product recalls, and defects, which may lead to costly liability lawsuits in the future. As quality control and consistent testing environments are pivotal for a successful manufacturing cycle, the focus on GMPs is increasing for avoiding product contamination, failure, and quality deviation. Thus, by establishing a strong system of well-regulated operational management led by GMPs, a medical device manufacturer can develop vast volumes of quality products, along with reducing costly delays. Thus, the above-mentioned factors are bolstering the growth of North America GMP testing service market .

North America GMP Testing Service Market Overview

The North America GMP testing service market is segmented into the US, Canada, and Mexico. The US held the largest share of the market in 2021. The growing pharmaceutical industry, and the increasing need for developing novel drugs and medical devices are accelerating the growth of the GMP testing service market in North America. Moreover, the rising health expenditure by governments and an increase in outsourcing activities for the quality assurance of medical products are propelling the expansion of this market in this region. The US holds a significant share of the North America GMP testing service market. The market growth in this country is attributed to rising healthcare expenditure by the government, ongoing developments in the pharmaceuticals industry, and rising demand for novel drugs owing to various infectious diseases.

North America GMP Testing Service Market Revenue and Forecast to 2028 (US$ Million)

North America GMP Testing Service Market Segmentation

The North America GMP testing service market is segmented on the basis of service type, end user, and country. Based on service type, the market is segmented into product validation testing, bioanalytical services, packaging & shelf life testing, and other services type. The product validation testing segment held the largest market share in 2022.

Based on end user, the North America GMP testing service market is bifurcated into pharmaceutical and biopharmaceutical companies, and medical device companies. The pharmaceutical and biopharmaceutical companies segment held a larger market share in 2022.

The North America GMP testing service market, by country, is segmented into the US, Canada, and Mexico. The US dominated the market share in 2022.

Eurofins Scientific; Almac Group; INTERTEK GROUP PLC; WuXi AppTec; Sartorius AG; North American Science Associates, Inc.; Nelson Laboratories, LLC.; Boston Analytical; Pace Analytical Services; and Thermo Fisher Scientific Inc. (PPD Inc.) are among the leading companies operating in the North America GMP testing service market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America needle-free injection systems market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the North America needle-free injection systems market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the needle-free injection systems market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution